Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
MRGE's Cash to Debt is ranked lower than
95% of the 1754 Companies
in the Global Health Information Services industry.

( Industry Median: 20.60 vs. MRGE: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
MRGE' s 10-Year Cash to Debt Range
Min: 0.07  Med: 25.00 Max: No Debt
Current: 0.09
Equity to Asset 0.16
MRGE's Equity to Asset is ranked lower than
93% of the 1549 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. MRGE: 0.16 )
Ranked among companies with meaningful Equity to Asset only.
MRGE' s 10-Year Equity to Asset Range
Min: 0.1  Med: 0.48 Max: 0.94
Current: 0.16
0.1
0.94
Interest Coverage 1.37
MRGE's Interest Coverage is ranked lower than
96% of the 1143 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MRGE: 1.37 )
Ranked among companies with meaningful Interest Coverage only.
MRGE' s 10-Year Interest Coverage Range
Min: 0.2  Med: 7.10 Max: 9999.99
Current: 1.37
0.2
9999.99
F-Score: 7
Z-Score: -0.12
M-Score: -2.63
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 11.56
MRGE's Operating margin (%) is ranked higher than
71% of the 1724 Companies
in the Global Health Information Services industry.

( Industry Median: 5.00 vs. MRGE: 11.56 )
Ranked among companies with meaningful Operating margin (%) only.
MRGE' s 10-Year Operating margin (%) Range
Min: -339.18  Med: 2.66 Max: 17.53
Current: 11.56
-339.18
17.53
Net-margin (%) 10.08
MRGE's Net-margin (%) is ranked higher than
68% of the 1724 Companies
in the Global Health Information Services industry.

( Industry Median: 3.15 vs. MRGE: 10.08 )
Ranked among companies with meaningful Net-margin (%) only.
MRGE' s 10-Year Net-margin (%) Range
Min: -348.38  Med: -3.95 Max: 18.05
Current: 10.08
-348.38
18.05
ROE (%) 29.32
MRGE's ROE (%) is ranked higher than
86% of the 1678 Companies
in the Global Health Information Services industry.

( Industry Median: 5.86 vs. MRGE: 29.32 )
Ranked among companies with meaningful ROE (%) only.
MRGE' s 10-Year ROE (%) Range
Min: -160.1  Med: -18.38 Max: 26.06
Current: 29.32
-160.1
26.06
ROA (%) 5.70
MRGE's ROA (%) is ranked higher than
57% of the 1762 Companies
in the Global Health Information Services industry.

( Industry Median: 3.06 vs. MRGE: 5.70 )
Ranked among companies with meaningful ROA (%) only.
MRGE' s 10-Year ROA (%) Range
Min: -115.72  Med: -3.86 Max: 19.46
Current: 5.7
-115.72
19.46
ROC (Joel Greenblatt) (%) 554.38
MRGE's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 1736 Companies
in the Global Health Information Services industry.

( Industry Median: 22.95 vs. MRGE: 554.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MRGE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5952.41  Med: 41.18 Max: 432.93
Current: 554.38
-5952.41
432.93
Revenue Growth (3Y)(%) -6.10
MRGE's Revenue Growth (3Y)(%) is ranked lower than
76% of the 1302 Companies
in the Global Health Information Services industry.

( Industry Median: 5.20 vs. MRGE: -6.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MRGE' s 10-Year Revenue Growth (3Y)(%) Range
Min: -28.7  Med: -1.45 Max: 36.1
Current: -6.1
-28.7
36.1
EBITDA Growth (3Y)(%) -12.60
MRGE's EBITDA Growth (3Y)(%) is ranked lower than
76% of the 1046 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. MRGE: -12.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MRGE' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -37  Med: -8.20 Max: 97.6
Current: -12.6
-37
97.6
EPS Growth (3Y)(%) -100.00
MRGE's EPS Growth (3Y)(%) is ranked lower than
98% of the 972 Companies
in the Global Health Information Services industry.

( Industry Median: 6.10 vs. MRGE: -100.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MRGE' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -21.95 Max: 170.5
Current: -100
0
170.5
» MRGE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

MRGE Guru Trades in Q2 2014

Paul Tudor Jones 28,225 sh (+2.28%)
» More
Q3 2014

MRGE Guru Trades in Q3 2014

Paul Tudor Jones 15,658 sh (-44.52%)
» More
Q4 2014

MRGE Guru Trades in Q4 2014

Jim Simons 467,755 sh (New)
Paul Tudor Jones 15,658 sh (unchged)
» More
Q1 2015

MRGE Guru Trades in Q1 2015

Jim Simons 1,005,155 sh (+114.89%)
Paul Tudor Jones 14,658 sh (-6.39%)
» More
» Details

Insider Trades

Latest Guru Trades with MRGE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 35.40
MRGE's P/E(ttm) is ranked lower than
73% of the 1093 Companies
in the Global Health Information Services industry.

( Industry Median: 26.40 vs. MRGE: 35.40 )
Ranked among companies with meaningful P/E(ttm) only.
MRGE' s 10-Year P/E(ttm) Range
Min: 27.48  Med: 53.71 Max: 587.5
Current: 35.4
27.48
587.5
PE(NRI) 30.50
MRGE's PE(NRI) is ranked lower than
67% of the 1087 Companies
in the Global Health Information Services industry.

( Industry Median: 26.20 vs. MRGE: 30.50 )
Ranked among companies with meaningful PE(NRI) only.
MRGE' s 10-Year PE(NRI) Range
Min: 23.67  Med: 55.57 Max: 705
Current: 30.5
23.67
705
P/B 7.63
MRGE's P/B is ranked lower than
97% of the 1614 Companies
in the Global Health Information Services industry.

( Industry Median: 2.71 vs. MRGE: 7.63 )
Ranked among companies with meaningful P/B only.
MRGE' s 10-Year P/B Range
Min: 0.56  Med: 4.55 Max: 31.79
Current: 7.63
0.56
31.79
P/S 2.36
MRGE's P/S is ranked lower than
53% of the 1701 Companies
in the Global Health Information Services industry.

( Industry Median: 2.19 vs. MRGE: 2.36 )
Ranked among companies with meaningful P/S only.
MRGE' s 10-Year P/S Range
Min: 0.24  Med: 2.12 Max: 11.94
Current: 2.36
0.24
11.94
PFCF 17.16
MRGE's PFCF is ranked higher than
64% of the 812 Companies
in the Global Health Information Services industry.

( Industry Median: 25.40 vs. MRGE: 17.16 )
Ranked among companies with meaningful PFCF only.
MRGE' s 10-Year PFCF Range
Min: 6.09  Med: 25.66 Max: 235
Current: 17.16
6.09
235
POCF 14.45
MRGE's POCF is ranked higher than
59% of the 1012 Companies
in the Global Health Information Services industry.

( Industry Median: 18.40 vs. MRGE: 14.45 )
Ranked among companies with meaningful POCF only.
MRGE' s 10-Year POCF Range
Min: 5.2  Med: 23.95 Max: 99999999.99
Current: 14.45
5.2
99999999.99
EV-to-EBIT 28.06
MRGE's EV-to-EBIT is ranked lower than
78% of the 1145 Companies
in the Global Health Information Services industry.

( Industry Median: 17.09 vs. MRGE: 28.06 )
Ranked among companies with meaningful EV-to-EBIT only.
MRGE' s 10-Year EV-to-EBIT Range
Min: -209.9  Med: 18.90 Max: 1533.3
Current: 28.06
-209.9
1533.3
PEG 50.83
MRGE's PEG is ranked lower than
98% of the 481 Companies
in the Global Health Information Services industry.

( Industry Median: 1.91 vs. MRGE: 50.83 )
Ranked among companies with meaningful PEG only.
MRGE' s 10-Year PEG Range
Min: 0  Med: 10.22 Max: N/A
Current: 50.83
Current Ratio 0.84
MRGE's Current Ratio is ranked lower than
88% of the 1590 Companies
in the Global Health Information Services industry.

( Industry Median: 2.08 vs. MRGE: 0.84 )
Ranked among companies with meaningful Current Ratio only.
MRGE' s 10-Year Current Ratio Range
Min: 0.64  Med: 1.51 Max: 6.5
Current: 0.84
0.64
6.5
Quick Ratio 0.78
MRGE's Quick Ratio is ranked lower than
88% of the 1590 Companies
in the Global Health Information Services industry.

( Industry Median: 1.94 vs. MRGE: 0.78 )
Ranked among companies with meaningful Quick Ratio only.
MRGE' s 10-Year Quick Ratio Range
Min: 0.42  Med: 1.45 Max: 5.88
Current: 0.78
0.42
5.88
Days Inventory 22.85
MRGE's Days Inventory is ranked lower than
56% of the 1012 Companies
in the Global Health Information Services industry.

( Industry Median: 17.83 vs. MRGE: 22.85 )
Ranked among companies with meaningful Days Inventory only.
MRGE' s 10-Year Days Inventory Range
Min: 7.82  Med: 24.43 Max: 265.45
Current: 22.85
7.82
265.45
Days Sales Outstanding 75.24
MRGE's Days Sales Outstanding is ranked lower than
61% of the 1486 Companies
in the Global Health Information Services industry.

( Industry Median: 69.02 vs. MRGE: 75.24 )
Ranked among companies with meaningful Days Sales Outstanding only.
MRGE' s 10-Year Days Sales Outstanding Range
Min: 59.29  Med: 88.20 Max: 142.77
Current: 75.24
59.29
142.77

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 3.35
MRGE's Price/Projected FCF is ranked lower than
74% of the 794 Companies
in the Global Health Information Services industry.

( Industry Median: 1.82 vs. MRGE: 3.35 )
Ranked among companies with meaningful Price/Projected FCF only.
MRGE' s 10-Year Price/Projected FCF Range
Min: 0.93  Med: 2.93 Max: 52.2
Current: 3.35
0.93
52.2
Price/Median PS Value 1.11
MRGE's Price/Median PS Value is ranked higher than
57% of the 1546 Companies
in the Global Health Information Services industry.

( Industry Median: 1.21 vs. MRGE: 1.11 )
Ranked among companies with meaningful Price/Median PS Value only.
MRGE' s 10-Year Price/Median PS Value Range
Min: 0.11  Med: 0.94 Max: 5.47
Current: 1.11
0.11
5.47
Earnings Yield (Greenblatt) (%) 3.60
MRGE's Earnings Yield (Greenblatt) (%) is ranked lower than
52% of the 1696 Companies
in the Global Health Information Services industry.

( Industry Median: 2.70 vs. MRGE: 3.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MRGE' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.1  Med: 3.00 Max: 7.8
Current: 3.6
0.1
7.8

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:MRJ.Germany,
Merge Healthcare Inc is a Delaware corporation founded in 1987. The Company develops enterprise imaging software solutions that facilitate the management of images to create a more effective and efficient electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the difficult challenges in health information exchange today, such as the incorporation of medical images and diagnostic information into broader healthcare IT applications, the interoperability of proprietary software solutions, and the ability to improve the efficiency and cost effectiveness of its customers businesses. The Companys solutions optimize processes for healthcare providers ranging in size from single provider practices to large health systems, to the sponsors of clinical trials and medical device manufacturers. It operates in two reportable segments: Merge Healthcare mainly generates revenue from the sale of software including upgrades; hardware, professional services, maintenance and electronic data interchange services. Merge DNA derives the vast majority of its revenue from software, professional services and hosting through subscription arrangements. Its product portfolio provides products and services to its customers, including Image Interoperability Platform iConnect: This interoperability and connectivity platform enables hospitals, imaging centers, Integrated Delivery Networks and Health Information Exchanges to create information exchanges within their environments and with other entities.,Clinical and Financial Information Systems - Digital Imaging Solutions: Picture Archiving and Communication Systems, specialty workstations and related applications manage the image workflow of a medical enterprise; Clinical information systems: These systems provide a complete electronic record of a medical procedure across a variety of specialties including Merge OrthoEMR for orthopaedics, and Merge RIS for radiology; Revenue Cycle Management: It offer software and services for the revenue cycle management of physician practices, Software Development Toolkits, Technologies and Platforms - Merge toolkits, technologies and platforms provide software developers with the necessary resources to assist in the timely development of new products and enhance existing products and Hosted Software Solutions for Clinical Trial Data Management It provide hosted software solutions for the collection, aggregation, analysis, reporting and overall management of clinical trials information. Its strategy is to be a provider of integrated, healthcare IT solutions and services that improve the exchange of healthcare information. It is subject to regulation in the U.S. by the Food and Drug Administration, including periodic FDA inspections, in Canada under Health Canadas Medical Devices Regulations, and in other countries by corresponding regulatory authorities.
» More Articles for MRGE

Headlines

Articles On GuruFocus.com
Weekly Three-Year Low Highlights: AGI, ARO, WTSL, MRGE Jan 20 2014 
Sector Watch: Application Software, Billionaires Hold Stocks on the Fringe Dec 29 2013 
2.45 Mar 26 2013 
Merge Technologies Inc. (MRGE) CFO & Treasurer Steven M Oreskovich sells 19,000 Shares Dec 20 2010 
Merge Technologies Inc. Reports Operating Results (10-K/A) Aug 26 2010 
Merge Healthcare Acquisition of Confirma Complete Sep 01 2009 
Merge Healthcare Set to Acquire Confirma Aug 07 2009 
Merge Healthcare Reports Best Operating Income in Three Years Jul 30 2009 
Merge Healthcare Announces Second Straight Quarter of Topline Revenue and EPS Growth Feb 12 2009 
Merge Healthcare Sets Fourth Quarter Earnings Call Date Jan 29 2009 

More From Other Websites
10-Q for Merge Healthcare, Inc. Jul 30 2015
MERGE HEALTHCARE INC Files SEC form 10-Q, Quarterly Report Jul 28 2015
Edited Transcript of MRGE earnings conference call or presentation 23-Jul-15 12:30pm GMT Jul 24 2015
Merge Healthcare Tops Q2 Earnings, Posts Record Bookings - Analyst Blog Jul 24 2015
Merge Reports Second Quarter Financial Results Jul 23 2015
Q2 2015 Merge Healthcare Inc Earnings Release - Before Market Open Jul 23 2015
Merge Healthcare beats 2Q profit forecasts Jul 23 2015
Merge Healthcare beats 2Q profit forecasts Jul 23 2015
MERGE HEALTHCARE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2015
Merge Reports Second Quarter Financial Results Jul 23 2015
Coverage initiated on Merge Healthcare by Dougherty & Company Jul 17 2015
Summa Health Collaborates with Merge Healthcare to Drive Population Health Initiatives Jul 09 2015
Summa Health Collaborates With Merge Healthcare to Drive Population Health Initiatives Jul 09 2015
Merge Schedules Second Quarter 2015 Earnings Call Jul 07 2015
Merge Schedules Second Quarter 2015 Earnings Call Jul 07 2015
Merge Healthcare Shares Move Following Toshiba Partnership Jun 29 2015
Toshiba America Medical Systems and Merge Healthcare Partner on Cardiology and Hemodynamic Solutions Jun 29 2015
Toshiba America Medical Systems and Merge Healthcare Partner on Cardiology and Hemodynamic Solutions Jun 29 2015
Merge Healthcare (MRGE) Shares March Higher, Can It Continue? - Tale of the Tape Jun 26 2015
MERGE HEALTHCARE INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Jun 19 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK